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Aim: To examine individual variability between perceived physical features and hormones
of pubertal maturation in 9–10-year-old children as a function of sociodemographic
characteristics.
Methods: Cross-sectional metrics of puberty were utilized from the baseline assessment
of the Adolescent Brain Cognitive Development (ABCD) Study—a multi-site sample of 9–
10 year-olds (n = 11,875)—and included perceived physical features via the pubertal
development scale (PDS) and child salivary hormone levels (dehydroepiandrosterone and
testosterone in all, and estradiol in females). Multi-level models examined the relationships
among sociodemographic measures, physical features, and hormone levels. A group
factor analysis (GFA) was implemented to extract latent variables of pubertal maturation
that integrated both measures of perceived physical features and hormone levels.
Results: PDS summary scores indicated more males (70%) than females (31%) were
prepubertal. Perceived physical features and hormone levels were significantly associated
with child’s weight status and income, such that more mature scores were observed
among children that were overweight/obese or from households with low-income. Results
from the GFA identified two latent factors that described individual differences in pubertal
maturation among both females and males, with factor 1 driven by higher hormone levels,
and factor 2 driven by perceived physical maturation. The correspondence between latent
factor 1 scores (hormones) and latent factor 2 scores (perceived physical maturation)
revealed synchronous and asynchronous relationships between hormones and
concomitant physical features in this large young adolescent sample.
Conclusions: Sociodemographic measures were associated with both objective
hormone and self-report physical measures of pubertal maturation in a large, diverse
sample of 9–10 year-olds. The latent variables of pubertal maturation described a
complex interplay between perceived physical changes and hormone levels that
hallmark sexual maturation, which future studies can examine in relation to trajectories
of brain maturation, risk/resilience to substance use, and other mental health outcomes.
Keywords: adolescent brain cognitive development, salivary hormones, pubertal development scale, puberty,
testosterone, dehydroepiandrosterone, estradiol
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INTRODUCTION
Puberty is an important developmental milestone that begins
with rising hormone levels and leads to physical changes in
secondary sex characteristics. Puberty contributes to individual
differences in brain maturation, cognition, emotion, and
psychosocial wellbeing (1, 2). Individual differences in the age
when physical changes emerge vary widely, with a typical onset
between 8 to 13 years in females and 9 to 14 years in males (3).
Moreover, variation in pubertal timing has been associated with
important psychological outcomes, including risk-taking
behavior (4, 5), depression symptomatology (6–9), and
substance use (10–12), with more advanced physical features
relating to more risk taking, depressive-like symptomatology and
substance use, on average. Although there are significant
implications of pubertal timing for health and wellbeing, the
foundational studies that are credited for our current
understanding of pubertal onset may not generalize to today’s
youth, as study samples often lacked diversity and consideration
of the larger sociodemographic context (3, 13–15). Thus, studies
are needed to expand our basic understanding of individual
differences in pubertal development in large samples of both
sexes (1), as well as in narrowed age ranges, to determine the
optimal approach to integrate multiple complex measures of
puberty for a given individual prior to exploring relationships
with developmental outcomes.
Estimates suggest that less than five percent of published
studies on puberty have examined normative patterns of
pubertal maturation as a function of race and ethnicity (1).
While replicable differences across racial and ethnic groups have
emerged, with earlier pubertal timing in participants identifying as
Black or Hispanic (16–19), many studies commonly report
findings in only one sex and largely fail to adequately account
for sociodemographic characteristics or other key biological
variables (e.g., child’s weight). However, in the United States,
race and ethnicity are greatly intertwined with socioeconomic
status. Further, some have postulated that racial and ethnic
differences in pubertal maturation could be due to differences in
weight status (18, 20, 21), given that the obesity epidemic has
disproportionately impacted minority and lower-income
communities (22). Being overweight or obese has been
associated with earlier pubertal timing among females, but
findings among males have been mixed (21, 23, 24) and are
often limited by lack of sample diversity. Efforts to better
understand pubertal timing must jointly consider socioeconomic
status, race/ethnicity, and obesity. Only a few studies have had
sufficiently large and diverse samples to begin to address
combinations of these factors, but none have addressed all three
factors in both sexes (18, 19, 25, 26). Therefore, the primary and
overarching aim was to examine how sociodemographic
characteristics relate to measures of pubertal maturation, such as
perceived physical changes and hormonal features of pubertal
status, in a large and diverse sample of children, all within a
narrowed age range (e.g., 9.00–10.99 years old).
The transition into puberty is driven by two processes:
adrenarche and gonadarche. Adrenarche is the maturation of
the adrenal glands and its release of adrenal androgens, including
dehydroepiandrosterone (DHEA), which contribute to the
development of pubic and axillary hair as well as body odor
(27). Gonadarche begins via release of gonadotropin releasing
hormone in the hypothalamus and downstream production of
gonadal steroids and the maturation of secondary sexual
characteristics (28). While both testosterone and estradiol
levels rise in both sexes, the magnitude of increase varies by
sex, with greater increases in testosterone for males and greater
increases in estradiol in females, due to additional release from
the ovaries. Higher levels of testosterone promote growth of the
penis and scrotum in males (29). Increases in estradiol in girls
lead to breast development as well as body fat distribution, and
eventually the later gonadal event of menarche (i.e., first
menstrual cycle) (30). The combined rise in sex steroids,
growth hormone, and insulin-like growth factor-1 (IGF-I)
during puberty contribute to the adolescent growth spurt (31).
Commonly used pubertal status measurements are based on
visible physical features by caregiver-report, self-report, or exam
by a trained clinician [see (32) for extensive review]. While
hormones drive physical changes, with hormonal events
preceding observable physical changes, the relationship
between hormones and physical maturation may occur in a
tissue-specific manner, such that different levels of hormones
may be required for changes in axillary hair compared to pubic
hair. Although correlated, physical maturation does not map
one-to-one with hormone levels in developing individuals (32),
and there is interindividual variability in timing, pubertal
pathways (e.g., pubic hair vs. breast development as the initial
sign), and pubertal hormone levels (33). For these reasons, there
is likely not a single “gold standard” for characterizing the
multifaceted process of changes in physical and hormonal
markers through pubertal development (34). Thus, further
studies are needed that assess and integrate individual
differences in complementary physical and hormonal markers
to push the field of puberty forward.
The current study leveraged multiple indicators of pubertal
maturation, including perceived physical development as
reported by the child and caregiver and salivary hormone
levels from the child, from the large sample of 11,880 children
participating in the Adolescent Brain Cognitive Development
(ABCD) StudySM in the U.S. (35, 36). By design, the ABCD
Study® enrolled 9–10 year-olds to capture the transition from
childhood through adolescence (37, 38). Given the narrow age
range, the ABCD Study provides an unparalleled opportunity to
examine differences in pubertal status without the added
complication of data manipulation and the confound of age.
Moreover, the ABCD Study also provides the necessary
variability and statistical power to disentangle the extent to
which sex, race/ethnicity, socioeconomic, and body weight are
associated with common markers of pubertal status at 9–10 years
of age. Lastly, we capitalized on the potentially unique, yet
complementary, information provided through integrating
both perceived physical features and hormone measures by
applying a group factor analysis (GFA) (39) to identify latent
variables of pubertal maturation.
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METHODS
Participants and Procedure
The ABCD Study® is a large-scale, 10-year longitudinal study
involving 21 data collection sites across the United States
(ABCDStudy.org) (35). Using school-based enrollment,
community events, and birth records to identify twins, the
consortium enrolled 11,880 children aged 9–10 years (38).
Briefly, inclusion criteria for the ABCD study were as follows:
1) age 9.00 to 10.99 years at the time of baseline assessment; 2)
able to validly and safely complete the baseline visit including
MRI; 3) fluent in English. Exclusionary criteria included any of
the following: a current diagnosis of schizophrenia, autism
spectrum disorder (moderate, severe), mental retardation/
intellectual disability, or alcohol/substance use disorder; non-
correctable vision, hearing or sensorimotor impairments, as
protocol elements may not be valid; major neurological
disorders, such as cerebral palsy, brain tumor, stroke, brain
aneurysm, brain hemorrhage, subdural hematoma, multiple
sclerosis, sickle cell disease, and the following seizure disorder
diagnoses: Lennox-Gastaut syndrome, Dravet syndrome, and
Landau Kleffner syndrome; gestational age less than 28 weeks,
and birthweight less than 1.2 kilograms (2 lb 10 oz); birth
complications, other than those associated with prematurity, that
resulted in being hospitalized for more than a month; a history of
traumatic brain injury; or MRI contraindications. Data from 11,875
of these subjects came from the ABCD 2.0.1 data release (DOI:
10.15154/1504041), which included baseline data (i.e., cross-
sectional). Centralized institutional review board (IRB) approval
was obtained from the University of California, San Diego. Study
sites obtained approval from their local IRBs. Written informed
consent was provided by each caregiver; each child provided written
assent. All ethical regulations were complied with during data
collection and analysis. Child and caregiver participants’ in-person
baseline visits were completed between September 2016 and
October 2018.
Self-Report Perceived Physical Maturation
In studying puberty, the measure of puberty chosen should
“match” the research question and the sample under study (32,
40). Given the narrow age range, the epidemiological nature of
the ABCD Study, and to minimize invasiveness, perceived
physical markers of pubertal maturation were assessed by the
youth and primary caregiver using the PDS scale (41). This
questionnaire was also chosen as self-reports on this scale have
been shown to correlate significantly with other measures of
pubertal status, including physician ratings (41). The PDS
consists of five questions regarding changes in height (i.e.
growth spurt), body hair (i.e. hair any place other than on the
head, such as under the arms), skin (i.e. pimples), voice, and
facial hair (males) or changes in height, body hair, skin, breast
development, and menarche (females). For each question,
caregivers and youth were asked to separately rate physical
development on a 4-point scale (1 = has not begun yet, 2 =
barely begun, 3 = definitely begun, 4 = seems complete), except
for the menarche question, which consisted of a yes/no answer
choice (yes = 4; no = 1). If menarche was reported, then follow-
up questions were asked about the child’s menstrual cycle
including age of first menstruation. An “I don’t know” option
was also available for each item for both caregiver and youth as
well as a “Refuse to answer” option on the youth self-report.
PDS values were utilized to calculate the following: average
PDS score (41), adrenal- versus gonadal-related average PDS
scores (42), and pubertal category score (43). These summary
scores were computed separately for caregiver versus child report
and separately for male and female participants. As previously
described (42), gonadal PDS scores were created for females by
averaging growth spurt, breast development, and menarche PDS
items; for males, by averaging growth spurt, deepening of voice,
and facial hair growth PDS items. Adrenal scores were created by
averaging pubic/body hair and skin changes from PDS items for
both males and females. The puberty category score was derived
for males by summing the body hair growth, voice change, and
facial hair items and categorizing them as follows: prepubertal = 3
(all one-point responses); early pubertal = 4 or 5 (no 3-point
responses); midpubertal = 6–8 (no 4-point responses); late
pubertal = 9–11; and, postpubertal = 12 (e.g. all 4-point
responses) (43). The puberty category score was derived for
females by summing the body hair growth and breast
development and using the menarche variable for categorizing
them as follows: prepubertal = 2 and no menarche; early pubertal
= 3 and no menarche; midpubertal =>3 and no menarche; late
pubertal <=7 and menarche; postpubertal = 8 and menarche (43).
For statistical purposes, items were considered as “missing” if
the response was left blank and/or answered with “I don’t know”
or “Refuse to answer”. In order to reduce over- or under-
estimation of the pubertal outcome variables, participants were
excluded if they had more than one “missing” value when
calculating the average PDS score (Supplemental Table 1). For
the more specific gonadal versus adrenal and pubertal category
scores, individuals were excluded from being assigned these
scores if any of the respective items were “missing”. Birth sex
was utilized to classify participants as male or female, and gender
identity was not incorporated into current analyses.
Saliva Collection and Determination of
Salivary Biomarkers
Given importance of assessing pubertal maturation with
biomarkers, ABCD selected salivary sampling for assessment of 3
gonadal hormones given its noninvasive nature, ability to be
collected without a phlebotomist, and ability to reliably reflect
hormone levels. Salivary biomarkers utilized whole saliva
collected via passive drool from each participating child with
assistance from trained research assistants in the laboratory. The
saliva collection was adapted from Granger and colleagues (44).
Briefly, participants did not have any food, snacks, drinks, gum,
candy, ormints in the 30min prior to collection, nomajor meals in
the 60 min prior to collection, and were asked to rinse their mouth
with water 10 min prior to saliva collection to remove particulates.
Collection times in the ABCD Study varied between 7:00 am and
7:00 pm. To protect the cold chain, samples were placed into a
Nalgene Labtop Cooler [chilled before sampling in on-site freezer
(-80° to -20°C) and kept inside a small lunchbox cooler]
Herting et al. Pubertal Development ABCD Study
Frontiers in Endocrinology | www.frontiersin.org February 2021 | Volume 11 | Article 5499284
immediately after collection. Depending on the site, saliva samples
were either placed inside an on-site freezer immediately after
collection, while some sites placed the sample within a cooler
placed inside a refrigerator (4°C) during neurocognitive testing,
and then saliva samples were stored in an on-site freezer by the end
of the testing day. Saliva samples were shipped 2–6 months after
collection on dry ice to Salimetrics (Carlsbad, CA) and promptly
assayed. All hormoneswere assayed in duplicate within a single day
to avoid multiple freeze-thaw cycles (testosterone and DHEA in
males and females, and 17-b estradiol in females only) using
commercially available immunoassays specifically designed for
use with saliva without modification to the manufacturers
recommended protocol (Salimetrics). The following specifications
are listed in order to reflect testosterone, DHEA, and estradiol:
calibrator ranges (6.1–600 pg/ml; 10.2–1,000 pg/ml; 1–32 pg/ml,
respectively); lower limits of sensitivity (1 pg/ml; 5 pg/ml; 0.1 pg/ml,
respectively), incubation time (1.5 h; 3.5 h; 2.5 h, respectively) and
correlation with serum (0.96; 0.86; 0.80, respectively).
To establish a single hormone value for each participant at
baseline, a decision-tree was implemented for conducting quality
control in each replicate value and to establish a final estimate of
hormone level, as presented in Figure 1. To determine whether
or not hormone levels varied as a function of methodological or
physiological factors independent of pubertal maturation, we
assessed relationships between hormone levels and the following
independent factors relating to salivary sample collection: 1)
collection time (minutes since midnight); 2) duration of salivary
collection (minutes from start to finish of active collection); and,
3) time taken to place saliva sample into freezer for storage
(minutes from collection finish time to placement into freezer
on-site). The physiological factors included 1) caffeine intake in
the past 12 hours (yes/no); and 2) vigorous physical exercise
within the past 12 hours (yes/no), as recorded by the researcher
from the child participant on the saliva collection day.
Body Mass Index and Sociodemographic
Variables
Anthropometric measurements of height and weight were taken
as the average of up to three separate measures using professional
grade equipment (e.g. physician weight beam scale with height
rod). These data were then used to calculate body mass index z-
scores (i.e., BMIz) and weight status (underweight: <5th
percentile; overweight: >85th to <95th; obese: ≥ 95th percentile)
based on the individual’s age and biological sex using the SAS
program provided by the 2000 CDC Growth Charts (ages 0 to 20
years) (45). ABCD’s Data Exploration and Analysis Portal
(DEAP) variables were used for race and ethnicity, as well as
socioeconomic factors. Specifically, race/ethnicity were
combined to generate dummy codes with five dichotomous
values, including White, Black, Hispanic, Asian, and Other/
Multi-race. Family socioeconomic status (SES) was assessed via
caregiver-reported total household income and highest
household education. Household income was collected in bins
(i.e. <$5,000, $5,000–$11,999, $12,000–$15,999, $16,000–
$24,999, $25,000–$34,999, $35,000–$49,999, $50,000–$74,999,
$75,000–$99,999, $100,000–$199,999, ≥$200,000). The DEAP
variables for income were binned into a categorical factor
representing low (<$50k), middle ($50–$100k) and high
(≥$100k) income. Highest education was defined as the highest
education attained among caregivers. It was reported in
incremental categories ranging from never educated/
kindergarten through doctoral-level graduate degree. The
DEAP variable of highest education was used, representing
categorical factors of less than high school (HS) education, HS
education/GED, Some College (including Associate’s Degree),
Bachelor’s Degree, and Postgraduate Degree.
Latent Factors of Pubertal Maturation
While other studies have examined association with individual
measures of hormonal and physical features (7, 16, 42, 46), we
also applied a group factor analysis (GFA) to derive latent factors
that encompassed integrated measures of both perceived physical
features and hormone levels. Factor analysis is a useful tool for
investigating constructs that are otherwise hard to directly
measure but can be indirectly measured by observed variables
(47). The goal of GFA is to identify latent factors that explain
relationships within groups of variables from relationships seen
between groups of variables (39). In the case of the current
analyses, given the collection of 2 groups of variables with
various dimensions (group 1: 5 response items from the PDS
and group 2: 2 (or 3 in females) hormone levels measured from a
salivary sample), the task is to identify factors that describe
dependencies between the multiple groups of variables, while
allowing for within-group factors that account for covariance
unique to each group. The GFA solution differs from canonical
correlation analysis or standard exploratory factor analysis by
utilizing a Bayesian inferential framework to place an Automatic
Relevance Determination prior on the factor solution, which
assumes a low-rank representation of the factor loading (48).
The main advantages of GFA are that it is conceptually simple, as
it differentiates within-group from between-group associations,
and it allows for factor analysis in scenarios with two or more
groups of data, giving factor solutions that are not merely
accounted for due to method variance resulting from one
variable grouping. The GFA solution comprises a set of factors
that contain a projection vector for each of the variable groups
having non-zero weights for that factor (39). Given that hormone
levels and physical features are dependent on biological sex, GFAs
were implemented separately for males and females. Latent
factors accounting for more than 10% of the variance were
chosen. To ensure factors were robust and to further test the
stability of the factors for PDS and hormones, we performed the
following: (1) GFA analyses were replicated ten times (averaged
factor loadings are presented); 2) split-half samples were
randomly generated to test replication in two separate sub-
samples; and, 3) GFA implementations were subsequently
extended to include sociodemographic measures by including
BMIz, then BMIz + SES (parental education and family income),
then pre-residualized BMIz + SES + race/ethnicity (Black,
Hispanic, Asian, White, Other). For completeness, in addition
to PDS items reported by caregivers, we also performed a GFA
using PDS values from youth self-report.
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Analytic Strategy
Statistical evaluation of the data was performed in R (version 3.6).
Group Factor Analyses [GFA (39, 49)] were conducted using the R
package GFA (50). Mixed-effects model analyses were conducted
using the R package nlme and/or gamm4 (51, 52). All mixed model
and GFA analyses were conducted with complete cases only. Data
are presented as mean, standard deviation, and frequencies.
Caregiver-youth agreement for PDS items was examined using a
polychoric correlation coefficient [rho (53)] and a weighted
Cohen’s kappa coefficient [k (54)]. The polychoric correlation is
useful for examining agreement between ordered category data
(53), whereas k is weighted to consider random chance of
agreement (54). Exploratory analyses were also performed to
examine if agreement varied as a function of the reporting
caregiver (i.e. biological mother versus biological father).
Separate mixed-effects models were performed for summary
scores of physical maturation and hormone levels to examine the
association of sociodemographic variables in relation to markers of
pubertal status. The sociodemographic variables were selected a
priori, which have all been shown to relate to puberty, based on
past literature (16–19, 23, 55). Variables included a main effect and
potential sex difference (i.e. interaction term) for age (in months),
race/ethnicity, highest household educationobtained, andhousehold
income. For the effect of age and age-by-sex interactions, we also
explored both linear and non-linear associations using the linear
mixed effect modeling (LME; R package nlme) and general additive
FIGURE 1 | Decision tree for quality checking and generating a single hormone metric per participant at baseline (9–10 years old) (e.g., saliva assayed in duplicates,
considerations for methodological concerns that may influence hormone level). Briefly, data were retained if (1) the sex specified during saliva collection matches sex
at birth, as reported by parent participants, (2) if a salivary hormone sample was collected, and (3) if that sample had been processed. Replicate samples that fell
below detection limits or were endorsed as problematic by research assistants (RAs) were not used to calculate participants’ hormone levels (4–6). NDS, not
detectable sample; R1, Replicate 1. R2, Replicate 2.
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modeling (GAM; gamm4), respectively. Given the study design and
nested data structure, all models included random intercepts for
ABCD site and family relationship for each participant as to account
for between-site variability and within-family correlations. In these
models, the reference groups for the categorical variables were age =
108 months, sex = male, ethnicity = Hispanic, parental education =
high school diploma/GED, total family income = middle ($50k–
$100k), and weight status = healthy weight. It is important to note
that the results do not differ as a function of changing the reference
group. In models for hormone levels, we also included important
methodological and physiological factors that may affect salivary
hormone levels, including caffeine intake (yes/no), physically active
(yes/no), time of collection since midnight (minutes), collection
duration (minutes), and time from collection to freeze (minutes).
RESULTS
Self-Reported Physical Markers of
Perceived Puberty
Item scores for caregiver and youth reports are presented in
Table 1. In females, the caregiver reporting was primarily the
biological mothers (86%) [biological fathers (8.9%), adoptive
parents (2.6%), custodial parent (1%), or other (1.5%)].
Similarly, the caregiver reporting for males was primarily
biological mothers (85%) [biological fathers (11%), adoptive
parent (2.6%), custodial parent (0.9%), or other (1.2%)]. Only
a small percentage of youth (≤1%) refused to answer any given
item (Table 1). A larger percentage of both males and females
reported “I don’t know” as compared to caregivers, especially for
Item 1 asking about growth in height (Table 1). Figure 2
presents the frequencies and distributions of summary scores
based on caregiver reports, and caregiver and youth reports for
summary scores are presented in Supplemental Table 1. Based
on the caregiver’s report, overall average PDS scores, gonadal,
and adrenal scores were higher (more mature) in females as
compared to males. Based on caregivers, 70.0% of males and
30.7% of females were perceived as prepubertal, 24.1% of males
and 23.5% of females were perceived as being in the early-
pubertal stage, and 5.3% of males and 43.0% of females were
reported to be in the mid-pubertal range. Youth, however,
reported more mature levels of perceived physical development
as compared to their caregivers, and male and female youth
reported similar overall PDS averages, gonadal, and adrenal
scores. Based on youth self-report, 29.9% of males and 25.6%
of females identified as being in the prepubertal stage, 47.62% of
males and 26.84% of females reported being in the early-pubertal
stage, and 20.5% of males and 44.2% of females identified as mid-
pubertal stage.
When examining the agreement between caregiver versus
youth report on the PDS (Table 2), rho values ranged from 0.18
to 0.38 for males and 0.27 to 0.98 for females. Kappa values
which consider possible agreement due to chance, ranged from
0.05 to 0.20 for males and 0.22 to 0.81 in females. Agreement
statistics were similar regardless of which caregiver completed
the PDS (biological father or mother) for males or females
(Supplemental Table 2). Given the previous literature showing
that youth tend to over-report their perceived physical
development at earlier ages (56), caregiver PDS scores were
utilized in examining perceived physical changes and
hormonal features in all further analyses.
Salivary Hormones
Mean hormone levels for males and females and methodological
covariates are presented in Table 3. No statistical hormone
outliers were observed. Despite a rather narrow age range, age-
related increases were seen in each hormone for both males and
females (Supplemental Figures 1–3).
Associations Between Physical and
Hormonal Features
In the sub-sample of youth with both hormone levels and
caregiver PDS, hormone levels are shown by perceived pubertal
category for females and males (Figure 3A, STable 3). As
expected, mean levels of DHEA (females: n = 1,713, F(4, 1,708)
= 45.4, p < 0.0000001; males: n = 2,383, F(4, 2,378) = 15.69, p <
0.0000001), testosterone (females: n = 1,713, F(4, 1,708) = 36.84, p
< 0.0000001; males: n = 2,383, F(4, 2,378) = 15.53, p < 0.0000001),
and estradiol (females: n = 1,733, F(4, 1,708) = 7.7, p < 0.0001)
were systematically higher for subsequent pubertal categories,
especially from the prepubertal to late pubertal stages. Using the
PDS average (Figure 3B), Gonadal score (Figure 3C), and
Adrenal score (Figure 3D), similar patterns of higher hormone
levels with more advanced perceived physical development across
the prepubertal to late pubertal stages, albeit with the exception of
extremely large variance seen at the most advanced physical stages
for males given the few subjects within these late stage categories.
Correlations between PDS summary scores and hormone levels
ranged from 0.13 to 0.19 in males and 0.10 to 0.34 in females
(Supplemental Table 3).
Sociodemographic Associations
A summary of sociodemographic characteristics by perceived
pubertal stage are reported in Table 4. Mixed-effects models to
examine the fixed effects for sex, age (in months), weight status,
race/ethnicity, parental education, and household income for
each PDS summary score and salivary hormone are presented in
Tables 5 and 6. The fixed effects accounted for more variance in
physical scores (Marginal R2: 0.21 to 0.32) as compared to
hormone levels (Marginal R2: 0.10 to 0.21). Associations
between age and physical features were found to be linear in
both sexes. In contrast, associations between age and androgen
levels were non-linear in females, but linear in males; suggesting
larger age-related increases in DHEA and testosterone in females
at age 10 than age 9. In contrast, estradiol levels were found to be
associated in a linear fashion with age. Adjusting for all
sociodemographic characteristics in the same model (i.e. age,
sex, weight status, race/ethnicity, highest education, and
household income), results also showed more advanced
pubertal maturation as indexed by either self-report of more
advanced physical features (Table 5) or higher androgen levels
(Table 6) for 1) females versus males, 2) overweight versus
healthy weight youth, and 3) those self-identifying as Black as
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TABLE 1 | Frequencies of scores reported on each item of the Pubertal Development Scale based on caregiver and youth report for each sex.
Caregiver Report Youth Report
Males Females Males Females
N = 6,141 N = 5,659 N = 6,158 N = 5,628
Height
Not Begun 22% (N = 1,381) 14% (N = 791) 14% (N = 844) 11% (N = 593)
Barely Started 20% (N = 1,231) 16% (N = 896) 20% (N = 1,246) 19%, (N = 1,048)
Underway 51% (N = 3,146) 63% (N = 3,543) 25% (N = 1,570) 22% (N = 1,257)
Complete 3% (N = 167) 4% (N = 208) 6% (N = 392) 6% (N = 362)
I don’t know 4% (N = 216) 4% (N = 221) 34% (N = 2,082) 42% (N = 2,339)
Refuse to answer – – <1% (N = 23) <1% (N = 28)
Body Hair
Not Begun 72% (N = 4,427) 52% (N = 2,922) 49% (N = 3,022) 46% (N = 2,578)
Barely Started 15% (N = 942) 20% (N = 1,153) 30% (N = 1,876) 30% (N = 1,691)
Underway 8% (N = 499) 23% (N = 1,277) 10% (N = 640) 12% (N = 690)
Complete 2% (N = 119) 3% (N = 160) 5% (N = 318) 5% (N = 309)
I don’t know 3% (N = 154) 3% (N = 147) 4% (N = 277) 6% (N = 324)
Refuse to answer – – <1% (N = 24) 1% (N = 34)
Skin Changes
Not Begun 73% (N = 4,492) 56% (N = 3,168) 50% (N = 3,098) 44% (N = 2,474)
Barely Started 18% (N = 1,116) 27% (N = 1,519) 25% (N = 1,569) 31% (N = 1,759)
Underway 6% (N = 358) 14% (N = 809) 7% (N = 435) 9% (N = 529)
Complete 1% (N = 62) 1% (N = 75) 3% (N = 157) 2% (N = 132)
I don’t know 2% (N = 113) 2% (N = 88) 14% (N = 873) 13% (N = 716)
Refuse to answer – – <1% (N = 25) <1% (N = 18)
Facial Hair
Not Begun 91% (N = 5,595) – 53% (N = 3,273) –
Barely Started 6% (N = 387) – 30% (N = 1,874) –
Underway 2% (N = 93) – 8% (N = 493) –
Complete <1% (N = 16) – 3% (N = 187) –
I don’t know 1% (N = 50) – 5% (N = 320) –
Refuse to answer – – <1% (N = 10) –
Voice Change
Not Begun 93% (N = 5,699) – 75% (N = 4,630) –
Barely Started 5% (N = 309) – 17% (N = 1,041) –
Underway 1% (N = 63) – 3% (N = 157) –
Complete <1% (N = 10) – 1% (N = 38) –
I don’t know 1% (N = 60) – 4% (N = 273) –
Refuse to answer – – <1% (N = 18) –
Breast Development
Not Begun – 39% (N = 2,208) – 31% (N = 1,736)
Barely Started – 35% (N = 1,973) – 35% (N = 1,977)
Underway – 24% (N = 1,372) – 13% (N = 755)
Complete – 1% (N = 48) – 2% (N = 126)
I don’t know – 1% (N = 57) – 17% (N = 959)
Refuse to answer – – – 1% (N = 68)
Menarche
Yes – 3% (N = 154) – 3% (N = 163)
No – 96% (N = 5,455) – 87% (N = 4,871)
I don’t know – 1% (N = 49) – 10% (N = 537)
Refuse to answer – – – 1% (N = 55)
Menarche Age (years) – –
7 <1% (N = 1) 1.8 (N = 3)
8 5.8% (N = 9) 7.4% (N = 12)
9 29.2% (N = 45) 31.3% (N = 51)
10 61.7% (N = 95) 53.4% (N = 87)
I don’t know 2.6% (N = 4) 5.5% (N = 9)
Refuse to answer – 6.1% (N = 1)
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compared to all other race/ethnicity categories (Figure 4,
Supplemental Tables 4–7). Effects of age, body weight status,
and race/ethnicity on physical and hormone outcomes were also
larger in females as compared to males (Figure 4, Supplemental
Tables 4–7). Lastly, associations between highest household
education and household income were only seen for self-report
measures of physical maturation, with higher education associated
with less physical maturation in both males and females and
higher household income associated with less physical maturation
in females (Table 5, Supplemental Tables 4–7).
Latent Variables for Physical and
Hormonal Features
Implementation of the GFA extracted four latent factors,
together explaining 44.5+/-1.0% of variability for males and
55.3+/-0.8% of variability in females in physical-hormone
pubertal relationships. Of these four latent factors, two of them
explained a large portion of the variability and showed robust
components through GFA iterations. The latent factor loadings
for the two most robust factors in males and in females are
presented in Figure 5.
A B
DC
FIGURE 2 | Frequencies (N) for caregiver summary scores from the Pubertal Development Scale (PDS). (A) Average PDS score ranging from 1=not begun to
4=complete; (B) Pubertal Category score ranging from pre- to post- pubertal; (C) Adrenal score averaging adrenal PDS items and ranging from 1=not begun to
4=complete; (D) Gonadal score averaging gonadal PDS items and ranging from 1=not begun to 4=complete.
TABLE 2 | Caregiver-youth agreement for Pubertal Development Scale items and summary scores by sex.
PDS Items Males Females
N Kappa (95% CI) Rho (SE) N Kappa (95% CI) Rho (SE)
Height 3,893 0.155 (0.12, 0.18) 0.18 (0.02) 3,122 0.22 (0.19, 0.25) 0.28 (0.02)
Body Hair 5,683 0.13 (0.10, 0.15) 0.21 (0.02) 5,120 0.37 (0.35, 0.40) 0.47 (0.01)
Skin Changes 5,125 0.195 (0.17, 0.22) 0.32 (0.02) 4,807 0.37 (0.34, 0.40) 0.46 (0.02)
Voice Change 5,770 0.143 (0.08, 0.12) 0.29 (0.02) 4,541 0.52 (0.49, 0.54) 0.62 (0.01)
Facial Hair 5,743 0.143 (0.11, 0.17) 0.38 (0.03) 4,980 0.81 (0.76, 0.86) 0.98 (0.01)
PDS Summary Scores N Kappa (95% CI) Rho (SE) N Kappa (95% CI) Rho (SE)
Average PDS 5,176 0.20 (0.17, 0.22) 0.23 (0.01) 4,229 0.53 (0.51, 0.56) 0.53 (0.01)
Gonadal Score 3,643 0.18 (0.15, 0.21) 0.22 (0.02) 2,501 0.55 (0.52, 0.59) 0.55 (0.01)
Adrenal Score 4,844 0.18 (0.15, 0.21) 0.26 (0.02) 4,491 0.44 (0.41, 0.47) 0.50 (0.01)
PDS Category 5,261 0.05 (0.03, 0.07) 0.25 (0.02) 3,936 0.22 (0.18, 0.26) 0.67 (0.01)
Kappa coefficient means (95% confidence intervals, CI) as well as polychoric coefficients rho (standard error, SE).
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In males, latent factor 1 (LF 1) accounted for 22.87% of the
variability among the metrics of physical features and hormones.
LF 1 was driven by androgen levels (DHEA and testosterone), and
to a lesser extent by skin and body hair, followed by height, facial
hair, and voice (Figure 5A). Specifically, higher LF 1 scores
indicated higher hormone levels with more maturation among
physical features, and lower LF 1 scores indicated lower hormone
levels with less maturation of physical features. Also inmales, latent
factor 2 (LF 2; Figure 5B) accounted for 15.77% of the variability
among the metrics of physical features and hormones, with the
strongest loadings observed for body hair, followed by facial hair,
skin, voice, and height, with weak loadings for androgen levels.
Therefore, LF 2 in males was primarily driven by physical features.
Male components 3–4 did not include hormone levels, but rather
explained less than 5% of the variability among physical features
(4.0 and 1.8%, respectively; data not shown).
For females, highly similar latent factors were extracted
compared to males. Latent factor 1 (LF 1; Figure 5C) in females
explained 31.16% of the variability among physical features and
hormone measures. Higher LF 1 scores indicated higher hormone
levels with more maturation of body hair, skin, and breast
development, and to a lesser extent for menarche and height;
indicating LF 1 primarily driven by hormones, as observed in
males. Again, similar to males, latent factor 2 (LF 2) for females
(Figure 5D) accounted for 16.35% of the variability among the
metrics of physical features and hormones, with the strongest
loadings for body hair, skin, breast development, and height as
compared to menarche and for estradiol, with DHEA and
testosterone demonstrating smaller effects. Together, LF 2 is
primarily driven by physical features in females, as was also
observed in males. Female components 3–4 did not include
hormone levels and only explained 5.0 and 2.9% of variability
among physical features, respectively (data not shown). In both
males and females, LF 1 and LF 2 were found to be robust, had
stable loadings, and were replicated in two split-half sub-samples as
well as in follow-up analyses that included BMIz, socioeconomic
status, and race/ethnicity as additional grouped variables in GFA
iterations (Supplemental Tables 8–11).
In both sexes, LF 1 scores indicate pubertal maturation as
indexed by hormone levels and to a lesser extent concomitant
maturation in physical features. LF 2 is orthogonal to LF 1 and is
mainly driven by residual increases in maturation of physical
features that are not necessarily associated with concomitant
increases in pubertal hormones. Interestingly, when evaluating
the correspondence between these two latent factors, how
synchronous an individual’s pubertal hormone levels are with
perceived changes in physical features can be evaluated. Plotting
the correspondence between LF 1 and LF 2 scores with each
individual’s hormone and average PDS values, unveiled unique
patterns reflecting individual differences as captured by these
latent factors of pubertal maturation (Figure 6). Specifically, the
correspondence between LF 1 and LF 2 described a profile of
synchronies (e.g., higher scores on both factors, or lower scores
on both factors) and asynchronies (a higher score on one factor
with a lower score on the other factor) in the pattern of how
physical and hormone measures relate to each other. Individuals
showing lower LF 1 and LF 2 scores are pre-pubertal based on
perceived sexual maturation and also have sex hormones within
the bottom 25th percentile of their same-sex peers at 9–10 years
of age. In contrast, individuals with higher LF 1 and LF 2 scores
are most advanced as evidenced by higher average PDS scores as
well as hormone levels within the top 75th percentile of their
same-sex peers at 9–10 years of age. However, widespread
variability in both LF 1 and LF 2 scores highlight that various
patterns of perceived physical features and hormone maturation
are rather common, such as having very high hormone levels but
perceived physical features that are deemed pre-pubertal (i.e. as
indexed by a higher LF 1, but a lower LF 2 score), or even having
rather low hormone levels as compared to peers, but more
advanced perceived physical features as captured by caregiver
report (i.e. as indexed by a lower LF 1, but a higher LF 2 score).
Lastly, we also explored if previously identified sociodemographic
differences would also be apparent using the combined estimates of
shared variance between physical and hormonal metrics of puberty
(LF 1 and LF 2) (Figure 7). Group differences were apparent for
weight status and race/ethnicitywhenplotting each subject’sLF1and
LF 2 (Figures 7A–D), but less so for highest education or household
income (Figures 7E–H). Overweight and obese individuals (as
compared to healthy or underweight youth) as well as Black youth
(compared toother race/ethnic categories)hadoverall higherpositive
LF 1 and LF 2 scores, suggesting greater pubertal maturation as
compared to their peers. In summary, unique patterns emerge when
TABLE 3 | Summary of hormone levels and salivary collection covariates in females and males.
Hormone Levels Males Females
N Mean ± SD IQR N Mean ± SD IQR
DHEA (pg/ml) 2,676 57.78 ± 43.78 50.04 2,430 76.87 ± 56.28 63.15
Testosterone (pg/ml) 2,622 32.80 ± 17.70 21.41 2,358 37.07 ± 18.37 22.94
Estradiol (pg/ml) – – – 2,168 1.17 ± 0.52 0.69
Covariates N Mean ± SD IQR N Mean ± SD IQR
Caffeine in past 12 hours (N) 2,376 Yes = 161/No = 2,210 – 1,707 Yes = 95/No = 1,612 –
Physical activity in past 12 hours (N) 2,366 Yes = 318/No = 2,048 – 1,703 Yes = 216/No = 1,487 –
Time Since Midnight (minutes) 2,381 777.58 ± 181.73 313 1,712 776.53 ± 177.18 311
Collection Duration (minutes) 2,318 6.81 ± 5.44 6 1,676 7.49 ± 5.89 5
Time to Freeze (minutes) 2,335 2.69 ± 12.31 1 1,686 3.05 ± 14.38 1
Mean and SD and Interquartile Range (IQR) unless otherwise noted.
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FIGURE 3 | Caregiver based Pubertal Development Scale (PDS) summary scores and hormone levels by sex. For each sex, hormone levels are plotted by PDS
summary scores, including (A) Pubertal Status Category, (B) Average PDS of all items, (C) Gonadal Score of PDS, and (D) Adrenal Score of PDS. Line represents
cubic spline function of the data. Females are plotted by menarche status.
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examining individual variability in the correspondence between
perceived physical features and sex hormone levels in 9–10 year-
olds, and sociodemographic differences can also be captured via the
integration of perceived physical and hormone markers of pubertal
maturation via GFA.
DISCUSSION
The present findings contribute to the scientific investigation of
pubertal maturation in several meaningful ways, including 1)
confirmed sociodemographic differences in pubertal status in a
recently collected large sample of 9–10 year-old children in the
United States, and 2) the identification of latent variables to
integrate physical and hormonal features towards a better
understanding of individual differences in pubertal maturation
alongside age- and sex- matched peers. Additionally, the present
study demonstrates the methodological feasibility of assessing
hormone levels on this historically large scale in youth, and
during the onset of pubertal maturation when levels are just
beginning to rise, using a non-invasive biological specimen: saliva.
Confirmation of sociodemographic differences in pubertal
status is important in the ABCD sample and in the narrow-age
range for the following reasons: 1) ABCD is a publicly available
data set, with an unprecedented release time, making utilization of
this sample for investigation of pubertal variables very feasible for
independent research groups across the world; and, 2) it confirms
previous research findings for sociodemographic associations with
pubertal maturation in a large, diverse sample of today’s children in
the United States. As is widely accepted in the literature (28, 57), on
average, females were of a more advanced pubertal stage at 9–10
years as compared to males, across a wide range of pubertal
measures (e.g., overall perceived physical features and adrenal-
and gonadal-related physical features), with larger non-linear
increases in androgen levels seen with age in females as
compared to males. As previously found, pubertal maturation
was more advanced among Black youth (18, 19), and related to
weight status (20–22) and (to a lesser degree in the present study)
factors reflecting socioeconomic status (16, 55). Interestingly, these
associations were more pronounced in females. The larger
associations between sociodemographic measures and pubertal
maturation in females as compared to males could possibly be
due to the increased variability in pubertal measures among females
compared to males within this narrow age range and should be
investigated in future ABCD releases as the children get older.
Alternatively, it may also be plausible that biological mechanisms
underlying pubertal maturation may be differentially affected by
sociodemographic characteristics in males versus females (55),
which also warrants future investigation.
The accuracy of measurement via self or caregiver-report of
physicalmaturation can vary based on the child’s sex,weight status,
and race/ethnicity (58, 59); thus, salivary hormone levels in the
current study are a complementary objective measurement. In fact,
salivary hormone levels, including DHEA, testosterone, and
estradiol, largely confirm sociodemographic differences as seen by
caregiver report on the PDS. As such, our results indicate that
sociodemographic measures of race/ethnicity and socioeconomic
status are associated with pubertal measures in a diverse sample of
TABLE 4 | Summary of sociodemographic variables for each Pubertal Development Scale derived categorical stage of perceived puberty based on caregiver report for
females and males.
Male Female
Pre Early Mid Late Post Pre Early Mid Late Post
N 4,140 1,422 314 29 4 1,664 1,278 2,328 138 6
Age (in months) 118.5 ± 7.43 120.5 ± 7.37 120.4 ± 7.25 122.1 ± 7.09 122.8 ± 8.18 115.9 ± 6.67 118.7 ± 7.39 120.5 ± 7.30 125.3 ± 5.37 126.8 ± 3.25
Weight Status
Healthy Weight 73.8% 21.6% 4.2% 0.3% 0.1% 38.4% 24.3% 35.9% 1.4% 0.0%
Underweight 79.4% 18.6% 2.0% 0.0% 0.0% 58.5% 21.4% 20.1% 0.0% 0.0%
Overweight 65.2% 27.7% 6.2% 0.9% 0.0% 13.6% 25.0% 55.8% 5.5% 0.1%
Obese 58.3% 31.2% 9.4% 1.0% 0.1% 8.1% 20.1% 66.2% 5.0% 0.6%
Race/Ethinicity
Hispanic 64.6% 26.8% 7.9% 0.7% 0.1% 26.7% 26.8% 42.0% 4.3% 0.2%
White 78.9% 19.4% 1.6% 0.1% 0.0% 38.4% 26.5% 34.3% 0.9% 0.0%
Black 41.4% 39.6% 16.7% 2.2% 0.1% 10.4% 9.8% 73.5% 5.8% 0.5%
Asian 73.7% 23.7% 2.6% 0.0% 0.0% 36.6% 32.5% 29.3% 1.6% 0.0%
Other 70.3% 23.2% 6.0% 0.2% 0.3% 27.9% 21.6% 47.8% 2.6% 0.0%
Highest Education
< HS Diploma 57.7% 28.0% 11.0% 2.8% 0.4% 18.1% 24.3% 52.1% 5.0% 0.4%
HS Diploma/GED 55.7% 27.4% 15.0% 1.6% 0.4% 17.9% 18.3% 58.0% 5.6% 0.2%
Some College 62.8% 28.1% 8.5% 0.5% 0.1% 22.3% 19.2% 54.6% 3.6% 0.2%
Bachelor 74.2% 22.6% 2.9% 0.2% 0.0% 34.7% 26.3% 37.0% 1.9% 0.1%
Post Graduate
Degree
77.4% 20.7% 1.8% 0.1% 0.0% 38.9% 26.2% 33.9% 1.0% 0.0%
Family Income
<50K 58.5% 30.4% 9.9% 1.1% 0.1% 18.9% 19.5% 56.3% 4.9% 0.3%
≥50K & <100K 71.7% 23.1% 4.6% 0.5% 0.1% 31.8% 23.7% 42.2% 2.3% 0.0%
≥100K 78.0% 20.1% 1.9% 0.0% 0.0% 39.5% 26.7% 32.8% 1.1% 0.0%
Mean and SD for age, and percentage of each categorical outcome across the 5 pubertal stages.
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youth and that this relationship is not entirely due to differences in
BMI. Given that the existing literature has found that normal onset
of pubertalmaturation tends to occur 1–2 years earlier in females as
compared tomales (60), it was unsurprising that approximately 2/3
of females but only 1/3 of males were at the early pubertal stage or
later. Given the less overt visible signs of early stages of puberty in
boys (2), the higher levels ofDHEA in females compared tomales in
the current study provide harmonizing evidence of sex differences
in pubertal onset.
The current findings also show that while accounting for each
variable during statistical modeling, race/ethnicity and body weight
status both uniquely related to more advanced physical and
hormonal makers of maturation in the ABCD cohort. As such, our
results are aligned with previous findings that Black youth develop
secondary sex characteristics earlier as compared to White youth
(24). Also, the racial and ethnic differences we found are congruent
with previous reports from large datasets [e.g., PROS (24, 46), and
NHANES (61) datasets]. For example, in PROS’s report,
approximately 68% of White and 95% of Black females were found
to display breast and/or pubic hair development by age 10 as
determined by a physician. Prevalence of pubic hair in PROS was
26% forWhite, 54% for Black, and 22% forHispanicmales by age 10
(24). Previous studies did not include Asian or Multi-race/Other as
individual groups, yet we found a similar prevalence of 26.7 and
28.6% for males and 62.4 and 72.4% for females having started the
pubertal process forAsianandMulti-race/Othergroups, respectively.
We found the highest averaged levels of DHEA, testosterone,
and estradiol (in females) in Black youth as compared to all other
racial and ethnic groups. It is still unclear why broad racial
groupings consistently relate to pubertal metrics. Importantly,
we must consider that the broad categories for race and ethnicity
in this study are neither biological nor genetic factors, but also
serve as proxies for a number of co-occurring factors, including
environmental factors, which together may influence the
TABLE 5 | Sociodemographic differences for Pubertal Development Scale summary scores.
Main Effects A) PDS Average B) Gonadal Score C) Adrenal Score
b CI p b CI p b CI p
Female (vs. Male) 0.07 -0.01 – 0.14 0.08 0.07 -0.004 – 0.14 0.06 0.03 -0.08 – 0.14 0.61
Interview age (months) 0.01 0.005 – 0.01 <0.001 0.004 0.002 – 0.005 <0.001 0.01 0.01 – 0.01 <0.001
Underweight (vs. Healthy Weight) -0.04 -0.09 – 0.02 0.18 -0.04 -0.10 – 0.01 0.14 -0.04 -0.12 – 0.05 0.37
Overweight (vs. Healthy Weight) 0.06 0.03 – 0.09 <0.001 0.06 0.03 – 0.09 <0.001 0.05 0.01 – 0.10 0.02
Obese (vs. Healthy Weight) 0.11 0.08 – 0.14 <0.001 0.09 0.06 – 0.12 <0.001 0.14 0.10 – 0.19 <0.001
White (vs. Hispanic) -0.06 -0.09 – -0.03 <0.001 -0.07 -0.11 – -0.04 <0.001 -0.04 -0.09 – 0.01 0.08
Black (vs. Hispanic) 0.16 0.12 – 0.20 <0.001 0.09 0.05 – 0.13 <0.001 0.27 0.21 – 0.33 <0.001
Asian (vs. Hispanic) -0.07 -0.15 – 0.01 0.08 -0.10 -0.18 – -0.02 0.02 -0.02 -0.15 – 0.10 0.70
Other (vs. Hispanic) -0.03 -0.07 – 0.01 0.19 -0.05 -0.09 – -0.01 0.02 0.01 -0.06 – 0.07 0.86
< HS Diploma (vs. HS Diploma/GED) -0.02 -0.09 – 0.04 0.49 0.02 -0.05 – 0.08 0.62 -0.11 -0.21 – -0.003 0.04
Some College (vs. HS Diploma/GED) -0.04 -0.08 – 0.01 0.10 -0.04 -0.08 – 0.002 0.06 -0.05 -0.12 – 0.02 0.15
Bachelor’s (vs. HS Diploma/GED) -0.09 -0.14 – -0.04 <0.001 -0.09 -0.14 – -0.05 <0.001 -0.11 -0.18 – -0.03 0.004
Post Graduate Degree (vs. HS Diploma/GED) -0.10 -0.15 – -0.06 <0.001 -0.12 -0.16 – -0.07 <0.001 -0.12 -0.20 – -0.05 0.001
Household Income <50K (vs. ≥50K & <100K) 0.02 -0.01 – 0.06 0.14 0.01 -0.02 – 0.05 0.40 0.04 -0.01 – 0.09 0.09
Household Income ≥100K (vs. ≥50K & <100K) -0.02 -0.05 – 0.004 0.09 -0.02 -0.05 – 0.01 0.11 -0.02 -0.06 – 0.02 0.30
Interactions b CI p b CI p b CI p
Female : Interview age (months) 0.02 0.01 – 0.02 <0.001 0.01 0.01 – 0.02 <0.001 0.02 0.01 – 0.02 <0.001
Female : Underweight (vs. Healthy Weight) -0.18 -0.26 – -0.10 <0.001 -0.17 -0.25 – -0.10 <0.001 -0.21 -0.32 – -0.09 <0.001
Female : Overweight (vs. Healthy Weight) 0.18 0.14 – 0.22 <0.001 0.18 0.14 – 0.23 <0.001 0.18 0.12 – 0.24 <0.001
Female : Obese (vs. Healthy Weight) 0.16 0.11 – 0.20 <0.001 0.21 0.16 – 0.25 <0.001 0.09 0.02 – 0.15 0.01
Female : White (vs. Hispanic) 0.04 -0.01 – 0.08 0.12 0.03 -0.01 – 0.08 0.15 0.05 -0.02 – 0.11 0.17
Female : Black (vs. Hispanic) 0.14 0.08 – 0.19 <0.001 0.11 0.06 – 0.16 <0.001 0.18 0.10 – 0.27 <0.001
Female : Asian (vs. Hispanic) 0.07 -0.04 – 0.18 0.23 0.11 -0.001 – 0.22 0.05 -0.04 -0.21 – 0.14 0.69
Female : Other (vs. Hispanic) 0.10 0.04 – 0.16 0.001 0.08 0.02 – 0.14 0.01 0.13 0.04 – 0.22 0.003
Female:<HS Diploma (vs. HS Diploma/GED) -0.01 -0.10 – 0.08 0.83 0.00 -0.09 – 0.09 1.00 0.06 -0.08 – 0.20 0.40
Female : Some College (vs. HS Diploma/
GED)
0.03 -0.03 – 0.10 0.27 0.02 -0.04 – 0.08 0.51 0.10 0.00 – 0.19 0.04
Female : Bachelor’s (vs. HS Diploma/GED) 0.02 -0.05 – 0.09 0.53 0.04 -0.03 – 0.10 0.30 0.04 -0.06 – 0.14 0.45
Female : Post Graduate Degree (vs. HS
Diploma/GED)
0.02 -0.05 – 0.09 0.52 0.04 -0.03 – 0.11 0.27 0.05 -0.06 – 0.15 0.38
Female : Household Income <50K (vs. ≥50K
& <100K)
0.01 -0.04 – 0.05 0.83 0.02 -0.03 – 0.06 0.45 -0.02 -0.09 – 0.05 0.63
Female : Household Income ≥100K (vs. ≥50K
& <100K)
-0.05 -0.09 – -0.01 0.02 -0.05 -0.09 – -0.02 0.01 -0.05 -0.11 – 0.01 0.11
Observations 10,424 10,293 10409
Marginal R2 0.32 0.30 0.21
Conditional R2 0.65 0.59 0.63
Each column reflects models including all variables by which the dependent variable is A) PDS Average, B) Gonadal Score C) Adrenal Score. Unstandardized beta (b) coefficients,
confidence intervals (CI), and p-values for each fixed effect in the model. Bold denotes significant values for p <0.05. Abbreviations: HS, High school; GED, General Education
Development. Income binned into a numerically coded factor representing low (<$50k), middle ($50–$100k), and high (≥$100k) income.
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biological etiology of pubertal maturation. Significant results
pertaining to these broad race and ethnicity groupings in this
study may also pertain to selection bias and omitted variables
underlying the study sampling technique. Elucidating the
relationship between pubertal maturation and co-occurring
factors that may be confounded with race and ethnicity is a
grossly understudied area that requires extensive and exclusive
attention in future studies designed to answer this line of inquiry.
In addition, the current study lends strong support for the
need to consider socioeconomic status and obesity in studying
pubertal development; especially given that each accounted for
unique variance in physical and hormonal markers of
maturation in the ABCD cohort. Although findings have
suggested overweight or obese status may lead to early
initiation of pubertal development in females (62), fewer
studies have been conducted in males and with mixed findings
TABLE 6 | Sociodemographic differences in hormone levels.
Smoothed Terms A) DHEA (pg/mL) B) Testosterone (pg/mL) C) Estradiol (pg/mL; females only)
edf p edf p edf p
s(age): Males 1.0 <0.001 1.0 <0.001 – –
s(age): Females 1.74 <0.001 1.33 <0.001 1.0 <0.001
Main Effects b CI p b CI p b CI p
Female (vs. Male) 25.87 12.636 – 39.101 <0.001 4.54 -0.222 – 9.291 0.06 – – –
Underweight (vs. Healthy Weight) -6.56 -16.915 – 3.792 0.21 -2.86 -6.599 – 0.884 0.13 0.01 -0.115 – 0.136 0.87
Overweight (vs. Healthy Weight) 9.87 4.487 – 15.25 <0.001 3.00 1.077 – 4.931 0.002 0.03 -0.033 – 0.100 0.32
Obese (vs. Healthy Weight) 24.39 19.014 – 29.774 <0.001 5.60 3.655 – 7.534 <0.001 0.07 0.002 – 0.136 0.04
White (vs. Hispanic) -4.78 -10.791 – 1.230 0.12 -0.09 -2.283 – 2.102 0.94 -0.06 -0.134 – 0.017 0.13
Black (vs. Hispanic) 14.93 7.044 – 22.81 <0.001 5.99 3.081 – 8.898 <0.001 0.11 0.013 – 0.203 0.03
Asian (vs. Hispanic) 3.64 -9.824 – 17.103 0.60 0.56 -4.300 – 5.422 0.82 -0.04 -0.202 – 0.115 0.59
Other (vs. Hispanic) -5.50 -13.522 – 2.526 0.18 0.50 -2.428 – 3.425 0.74 0.03 -0.065 – 0.129 0.52
<HS Diploma (vs. HS Diploma/GED) 1.78 -10.753 – 14.311 0.78 2.67 -1.850 – 7.180 0.25 0.00 -0.146 – 0.143 0.98
Some College (vs. HS Diploma/GED) -7.13 -15.085 – 0.823 0.08 -2.92 -5.797 – -0.045 0.05 0.03 -0.069 – 0.134 0.53
Bachelor's (vs. HS Diploma/GED) -3.89 -12.577 – 4.803 0.38 -2.37 -5.512 – 0.779 0.14 0.10 -0.008 – 0.210 0.07
Post Graduate Degree (vs. HS Diploma/
GED)
-1.78 -10.626 – 7.072 0.69 -2.12 -5.308 – 1.074 0.19 0.11 -0.003 – 0.222 0.06
Household Income <50K (vs. ≥50K &
<100K)
-1.70 -7.657 – 4.253 0.58 0.33 -1.833 – 2.486 0.77 0.07 -0.001 – 0.141 0.05
Household Income ≥100K (vs. ≥50K &
<100K)
-0.66 -5.747 – 4.423 0.80 -0.64 -2.480 – 1.209 0.50 0.03 -0.035 – 0.086 0.41
Interactions b CI p b CI p b CI p
Female: Underweight (vs. Healthy Weight) -1.52 -16.552 – 13.517 0.84 0.97 -4.421 – 6.360 0.72 – – –
Female: Overweight (vs. Healthy Weight) 1.07 -6.811 – 8.940 0.79 -0.39 -3.221 – 2.443 0.79 – – –
Female: Obese (vs. Healthy Weight) -3.21 -11.105 – 4.677 0.43 -0.98 -3.823 – 1.873 0.50 – – –
Female: White (vs. Hispanic) -5.22 -13.241 – 2.799 0.20 -1.40 -4.292 – 1.485 0.34 – – –
Female: Black (vs. Hispanic) 6.09 -4.494 – 16.671 0.26 3.63 -0.192 – 7.459 0.06 – – –
Female: Asian (vs. Hispanic) 0.01 -18.638 – 18.664 1.00 5.82 -0.842 – 12.481 0.09 – – –
Female: Other (vs. Hispanic) -2.34 -13.409 – 8.729 0.68 -1.06 -5.060 – 2.939 0.60 – – –
Female: <HS Diploma (vs. HS Diploma/GED) -15.11 -32.626 – 2.404 0.09 -4.35 -10.695 – 1.998 0.18 – – –
Female: SomeCollege (vs. HSDiploma/GED) -3.47 -15.171 – 8.240 0.56 1.04 -3.173 – 5.247 0.63 – – –
Female: Bachelor's (vs. HS Diploma/GED) -8.02 -20.662 – 4.621 0.21 0.11 -4.454 – 4.676 0.96 – – –
Female: Post Graduate Degree
(vs. HS Diploma/GED)
-12.18 -25.105 – 0.741 0.07 -1.29 -5.950 – 3.361 0.59 – – –
Female: Household Income <50K
(vs. ≥50K & <100K)
4.47 -3.928 – 12.86 0.30 -0.32 -3.362 – 2.716 0.84 – – –
Female: Household Income ≥100K
(vs. ≥50K & <100K)
6.70 -0.463 – 13.858 0.07 1.48 -1.111 – 4.067 0.26 – – –
Covariates b CI p b CI p b CI p
Caffeine in Past 12 hours (Yes) -3.09 -8.913 – 2.741 0.30 -1.04 -3.142 – 1.058 0.33 0.11 0.01 – 0.21 0.03
Physically active in Past 12 hours (Yes) 0.58 -3.761 – 4.914 0.79 -1.14 -2.699 – 0.410 0.15 0.07 -0.002 – 0.141 0.06
Since Midnight in minutes -0.01 -0.017 – 0.001 0.08 -0.003 -0.007 – -0.0002 0.04 0.0003 0.0002 – 0.0005 <0.001
Collection Duration in minutes 0.61 0.357 – 0.866 <0.001 0.25 0.160 – 0.342 <0.001 0.01 0.003 – 0.011 0.001
Time to Freeze sample in minutes -0.02 -0.129 – 0.100 0.80 -0.02 -0.065 – 0.017 0.25 0.00 -0.002 – 0.001 0.64
Observations 4455 4349 1908
Adjusted R2 0.21 0.18 0.10
Each column reflects models including all variables by which the dependent variable is A) DHEA, B) Testosterone, C) Estradiol. Effective Degrees of Freedom (edf) for smoothed effects of
age and unstandardized beta (b) coefficients, confidence intervals (CI), and p-values for each fixed effect in the model. Bold denotes significant values for p <0.05. Abbreviations: HS, High
school; GED, General Education Development. Income binned into a numerically coded factor representing low (<$50k), middle ($50–$100k) and high (≥$100k) income.
Herting et al. Pubertal Development ABCD Study




FIGURE 4 | Post-hoc comparisons of sex differences in the associations between sociodemographic measures and pubertal outcomes of (A) PDS Average, (B) DHEA,
(C) Estradiol, (D) Testosterone. Means and standard error (SE) for the fixed effects of weight status, race/ethnicity, highest parental education, and household income by sex,
while adjusting for means of all other variables in the model. Lines denote p <0.05 using Tukey multiple comparison correction. HS, High school; GED, General Education




FIGURE 5 | Latent factor loadings (median and 95% confidence intervals) of each predictor as identified by the two robust components of the group factor
analyses. These analyses examined within and between variance in both perceived physical changes from the PDS as well as hormone levels in males (A, B) and
females (C, D). These two latent factors capture the wide range of individual variability seen between physical and hormone metrics of early puberty among children,
with latent factor 1 driven by hormone levels, and the latent factor 2 driven by physical maturation. Latent factor 1 accounted for 22.87% of variance of the pubertal
measurements in (A) males and 31.16% in females (C). Latent factor 2 accounted for 15.77% of variance of the pubertal measurements in males (B) and 16.35% in
females (D).
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regarding an earlier onset versus delay in the initiation of the
pubertal process (21). More advanced physical maturation,
including higher androgen levels, were seen in overweight and
obese children of both sexes in the ABCD cohort, albeit effects
were larger for females. These findings corroborate previous
findings of increased testosterone levels in obese prepubertal and
pubertal girls from Germany (63) and in the United States (62),
as well as higher DHEA levels in obese prepubertal boys in China
as compared to normal weight peers (23). Less mature patterns
of physical maturation in relation to higher socioeconomic
position have also been noted before in other cohorts (55).
Future studies using the ABCD cohort are warranted to
determine if these associations may be due to other family or
neighborhood-wide social and environmental factors (64), stress,
or exposure to endocr ine d i s ruptors , which may
disproportionately affect low-income families and their
communities [or specific races via unregulated beauty products
containing endocrine disruptors (65)]. Physical and hormonal
changes do not occur in isolation during puberty: there is a bi-
directional cross-talk between the Hypothalamic Pituitary
Gonadal (HPG)-axis and the Hypothalamic Pituitary Adrenal
(HPA) stress axis in later stages of pubertal maturation, with
each system thought to be sensitive to physical and social
stressors (66). As the ABCD Study progresses, the breadth of
data as well as the longitudinal design will provide the
opportunity to examine how sociodemographic and
environmental factors map onto temporal patterns of pubertal
maturation across adolescence; ultimately strengthening our
understanding of the potential causal relationships between
environmental factors and pubertal timing and tempo (67).
The similarity of patterns seen in how physical and hormone
markers of puberty relate to sociodemographic characteristics
highlights agreement in physical and hormone markers at early
stages of pubertal maturation. However, we derived latent factors
to further characterize the individual variability in pubertal
maturation and capture the multifaceted, physical, and
hormonal cascade of the early stages of the pubertal process.
Two puberty related latent factors emerged for both males and
females, the first driven by hormone levels and the second driven






FIGURE 6 | Individual differences in pubertal maturation as characterized by latent factors. Plots show individual scores (lighter, smaller colored shapes) as well as
group-means (darker, larger colored shapes) of latent factor 1 (LF 1) and latent factor 2 (LF 2) in females (A–C) and males (D, E) by average score of physical
features reported on the Pubertal Development Scale (PDS) (shape) as well as quartile range (color) of testosterone (A, D), DHEA (B, E), or estradiol (C). Opposite of
each axis shows the marginal density plot of each latent factor as a function of each quartile of the given hormone (top: LF 1 by hormone density plot, right: LF 2 by
hormone density plot). The correspondence between the two latent factors together captures synchrony and asynchrony between hormones and concomitant
perceived physical features across this large child sample (F). Synchronous patterns are represented among individuals with a lower LF 1 and lower LF 2 scores who
are pre-pubertal with low hormone levels (pink circle), and among individuals with a higher LF 1 and higher LF 2 scores who are the most advanced in physical
maturation with high hormone levels (purple square or cross-hair). Opposing scores between LF 1 and LF 2 (e.g. higher LF 1 but lower LF 2 scores, or lower LF 1
but higher LF 2 scores) indicate a more asynchronous pattern between hormone levels and physical features.
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two factors described a profile of synchronies (e.g., a higher score
on both factors, or a negative score on both factors) and
asynchronies (e.g., a higher score on one factor with a lower
score on the other factor) in the relationship between physical
features and hormone levels. Importantly, these two factors
showed stability under multiple iterations accounting for
potential confounds of sociodemographic measures. Further,






FIGURE 7 | Latent factors and sociodemographic characteristics. Plots show individual scores (lighter, smaller colored shapes) as well as group-means (darker,
larger colored shapes) of latent factor 1 (LF 1) and latent factor 2 (LF 2) in females and males by weight status (A, B), race/ethnicity (C, D), highest parental
education (E, F), and household income (G, H). Opposite of each axis shows the marginal density plot of each latent factor as a function of each sociodemographic
measure. Group differences in pubertal maturation is apparent after integrating hormone levels and physical features using individual latent factors, with more
advanced pubertal maturation seen (higher LF 1 and LF 2 scores) for overweight/obese versus underweight/healthy weight (A, B) as well as Black versus White,
Hispanic, Asian, and Other (multi-race) (C, D) with larger effects seen in females as compared to males.
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sociodemographic differences, factor scores were associated with
sociodemographic measures such that more advanced patterns
of pubertal maturation were observed in youth identifying as
Black, as well as youth with overweight or obese status regardless
of race. Future studies are needed to understand the mechanisms
by which individual variability and patterns of synchrony emerge
in pubertal maturation and whether these patterns remain stable
or change with time. Possible mechanisms include variability in
tissue sensitivity to hormones (68) such that some individuals
may exhibit a higher degree of physical maturation with lower
levels of hormones, genetic factors, or variability in
environmental factors contributing to relative differences in
hormones and/or physical features of maturation (69). Lastly,
the hormone-related factor explained the most variability among
all pubertal measures and this may speak to possible differences
in the sensitivity of each metric to assess puberty during its early
stages, with potential greater sensitivity at the level of hormones
versus the less sensitive PDS measure via self or caregiver-report.
From a methodological perspective, the present findings
validate salivary sampling on a large scale, as age- and sex-
associated patterns in hormone levels were congruent with
theoretical predictions for a population of 9–10 year-olds who
primarily have not yet begun or are in early stages of pubertal
maturation. This is the largest salivary investigation of early
puberty in adolescents to date, thus demonstrating the feasibility
of collecting meaningful saliva-based hormone levels on this large
scale as a significant contribution to the field of salivary
biosciences. Salivary sampling is less invasive than blood and
can be collected in a variety of settings by trained research staff or
even self-sampled outside of the laboratory allowing for increased
ecological validity of salivary measures in the future.
Methodological measures that were expected to influence
hormone values were observed in the present study, including: a
negative association between time of collection and testosterone
levels, and positive associations between estradiol in girls with time
of collection, collection duration, and caffeine consumption. These
methodological considerations (e.g., time of day or time since
waking) are predicted to exert larger effects on hormone levels
with increased maturation of the HPG axis in later stages of
puberty, at which time adult-like circadian patterns become more
established (70). As hormones rise rapidly in future assessments in
the ABCD cohort, longitudinal analyses controlling for these
methodological factors around saliva collection will become
increasingly important and likely explain some variance in
absolute hormone levels unrelated to pubertal maturation. For
example, potential changes in collection times within and between
participants across years may contribute to artificial declines/
increases in hormone levels due to circadian fluctuations. Here,
salivary hormone levels are not being proposed for diagnostic
purposes, but rather as guides for expected ranges of hormone
values among 9–10 year olds participating in research studies. In
fact, this large-scale study provides more validation for salivary
hormone levels as important tools for studying child development
within the realm of research. In past research, salivary estradiol
levels have received less attention than testosterone or DHEA, and
have historically been considered too low in pre or early pubertal
children to be utilized as a reliable tool for clinical diagnosis,
regardless of sampling blood or saliva (71). To the contrary, we
believe what is largely missing from the literature is a large enough
data set for salivary hormones in typically developing children to
serve as “reference ranges or norms”, particularly for estradiol.
Limitations of the current analyses should be noted. The
ABCD Study implemented the PDS measurement of pubertal
maturation given its advantage of being brief and relatively
noninvasive and validated compared to traditional Tanner
Staging by physician, and that the PDS it is widely used in the
literature. However, PDS values can be biased based on self-
report by caregiver or child (72, 73). The ABCD Study does not
capture the transition of individuals into puberty for some of
the earliest developers, particularly females who identify as
Black. In addition, testicular volume is a hallmark of early
HPG activation and puberty onset in males. Thus, PDS may not
adequately capture earlier pubertal events in boys (1).
Therefore, a physical exam by a qualified physician is
required for an objective assessment of the earliest stages of
puberty in both sexes.
In ABCD, we relied on self- and caregiver- report that reflect
“perceived” physical pubertal development rather than relying
on clinician ratings which would have been too cumbersome and
costly in such a large sample in light of all the other time
consuming evaluations. Using this measurement, the majority
of the females in the sample (96%) had yet to complete the key
pubertal milestone of menarche at baseline; however,
approximately 10 females were reported to have experienced
menarche rather early at ages 7–8 years. The current study did
not collect information regarding potential evaluation by a
pediatric endocrinologist to determine if these individuals
would meet clinical criteria for extreme cases of early puberty,
including precocious puberty (as defined as occurring in females
<8 years or males <9 years) that affects as many as 1:5,000
children (74). It is also important to note that caregivers and
youth may overestimate perceived growth using the PDS. For
example, caregivers considered 51% of males and 63% of females
to have a growth spurt that was underway. Peak height velocity
typically occurs between ages 10–14 years for females and age
12–16 years for males (13). Thus, future analyses using the
ABCD dataset may benefit from calculation of peak height
velocity using objective anthropomorphic measures as well as
examination of age at menarche in females, as these metrics may
be a more objective measure of pubertal timing (75).
A primary limitation of this study is the cross-sectional nature
of the data utilized, particularly given the longitudinal and
dynamic nature of pubertal maturation. In an Australian
cohort where hormone levels were assayed from urine across 3
years from age 11–14 years, two phenotypes of longitudinal
hormone trajectories were found: either “smoother” or “bumpy”
(76). Future analyses using ABCD salivary pubertal hormone
markers longitudinally as they become available will help
interpret similarities or differences in observed trajectories
measured in urine or blood.
Regarding limitations of salivary hormone levels in this study,
the oral environment can impact accuracy of measurement of
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analytes, resulting in an over- or under-estimation of unbound
steroid hormone levels relative to bound levels. Despite these
caveats, correlations between blood levels with saliva using
immunoassays to assess DHEA, testosterone, and estradiol can
vary across time of day, pubertal stage, and context and are in
general 0.86, 0.96, and 0.80, respectively (28, 30, 77–81).
Correlations between serum and saliva reflect differences in
methodology, sensitivity of specimen, and assessment
methodology, as well as mechanistically relating to how
hormones arrive in the blood versus saliva. Blood is often
considered the clinical gold standard for accuracy of biomarker
levels, whereas saliva has unique benefits that make it feasible to
be utilized in any ecological context, including self-assessment in
the absence of a phlebotomist. Estradiol with immunoassay may
have reduced sensitivity to pubertal maturation during the
earliest stages, making associations of estradiol and physical
maturation less meaningful early on (as in the present
analyses) and more meaningful with future longitudinal time
points in ABCD. DHEA sulfate (DHEA-S) is a key hormone
precursor to DHEA, then testosterone, then estradiol, and was
not assayed in collected saliva in ABCD. Future studies that
include DHEA-S (potentially within the ABCD cohort) may
provide a more comprehensive panel to determine changes in
hormone metabolism across pubertal development.
In conclusion, the present findings characterize associations
between physical and hormonal sexual maturation in 9–10
year-old children and integrate key sociodemographic
information in mapping early stages of sexual maturation.
Sociodemographic differences in physical and hormonal
markers highlight the complex interplay between racial and
ethnicity backgrounds, physical health, and socioeconomic
factors at the early stages of pubertal maturation. Further, this
study demonstrates feasibility and validity of salivary hormone
sampling on a large scale and provides a novel approach in
characterizing complex pubertal maturational patterns as seen
by various measurements. Application of a factor analysis
approach (GFA) to the pubertal research niche allowed us to
reduce the dimensionality across several measures for
hormones and physical features to produce two factors, which
together can help to understand a large degree of the individual
variability in how physical features relate to hormone levels at
ages 9–10 years, and where an individual’s pattern in this
relationship between multiple metrics of puberty is located
relative to age- and sex- matched peers. Through future
exploration of how physical and hormonal markers relate to
each other and in connection to a wide range of developmental
outcomes, the ABCD Study holds great potential for rapid
advancement in understanding the universal biological
phenomenon of puberty and how it impacts both typical and
pathological pediatric health trajectories moving forward.
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